| Title | Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study. |
| Publication Type | Journal Article |
| Year of Publication | 2022 |
| Authors | Fangusaro JR, Onar-Thomas A, Poussaint TYoung, Wu S, Ligon AH, Lindeman NIan, Banerjee A, Packer R, Kilburn LB, Pollack IF, Qaddoumi IA, Fisher PGraham, Dhall G, Baxter PAnn, Kreissman SG, L Doyle A, Smith MA, Fouladi M, Dunkel IJ |
| Journal | Neuro Oncol |
| Volume | 24 |
| Issue | 8 |
| Pagination | 1404 |
| Date Published | 2022 Aug 01 |
| ISSN | 1523-5866 |
| DOI | 10.1093/neuonc/noac029 |
| Alternate Journal | Neuro Oncol |
| PubMed ID | 35307742 |
| PubMed Central ID | PMC9340620 |
| Grant List | P30 CA008748 / CA / NCI NIH HHS / United States UM1 CA081457 / CA / NCI NIH HHS / United States |
Related Faculty:
Neal Lindeman, M.D.